ArticleAntibodies (Basel, Switzerland)2025

The Use of Heterologous Antigens for Biopanning Enables the Selection of Broadly Neutralizing Nanobodies Against SARS-CoV-2.

Vazirbek S Aripov et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.